Theralase Technologies is selling for under 0.18 as of the 25th of November 2024; that is 5.88 percent increase since the beginning of the trading day. The stock's last reported lowest price was 0.18. Theralase Technologies has over 55 % chance of experiencing financial distress in the next 2 years of operation, but had a somewhat ok returns during the last 90 days. Equity ratings for Theralase Technologies are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of October 2024 and ending today, the 25th of November 2024. Click here to learn more.
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Theralase Technologies' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Theralase Technologies or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Theralase Technologies (TTX) is traded on Stuttgart Exchange in Germany . The company currently falls under 'Micro-Cap' category with a current market capitalization of 47.68 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Theralase Technologies's market, we take the total number of its shares issued and multiply it by Theralase Technologies's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Theralase Technologies generates negative cash flow from operations
Check Theralase Technologies Probability Of Bankruptcy
Theralase Technologies Risk Profiles
Although Theralase Technologies' alpha and beta are two of the key measurements used to evaluate Theralase Technologies' performance over the market, the standard measures of volatility play an important role as well.
Our tools can tell you how much better you can do entering a position in Theralase Technologies without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Portfolio Optimization Now
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
When running Theralase Technologies' price analysis, check to measure Theralase Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theralase Technologies is operating at the current time. Most of Theralase Technologies' value examination focuses on studying past and present price action to predict the probability of Theralase Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theralase Technologies' price. Additionally, you may evaluate how the addition of Theralase Technologies to your portfolios can decrease your overall portfolio volatility.